Anti-PGP9.5 antibody
Specifications
| Product Cat#: | AB-06-3446 |
| Product type: | Primary antibody |
| Antigen: | PGP9.5 |
| Immunogen: | Synthetic peptide within C-terminal human PGP9.5. |
| Species immunized: | Mouse |
| Isotype: | IgG2a |
| Applications: | Western Blot (1:450); Immunocytochemistry (1:190); Immunohistochemistry (1:40-1:5200); Flow Cytometry (1:40-1:100) |
| Reactivity: | Human,Mouse,Rat |
| Clonality (clone number): | Monoclonal (B1-5-6) |
| Form: | Liquid |
| Buffer: | Tris-HCl buffer (pH7.4), 1% BSA;50% glycerol, 0.05% NaN3. |
| Concentration: | 2 mg/ml |
| Purity: | Peptide affinity purified. |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | Epididymis luminal protein 117 antibody |
| Epididymis secretory protein Li 53 antibody | |
| HEL 117 antibody | |
| HEL S 53 antibody | |
| NDGOA antibody | |
| Neuron cytoplasmic protein 9.5 antibody | |
| OTTHUMP00000218137 antibody | |
| OTTHUMP00000218139 antibody | |
| OTTHUMP00000218140 antibody | |
| OTTHUMP00000218141 antibody | |
| Park 5 antibody | |
| Park5 antibody | |
| PGP 9.5 antibody | |
| PGP9.5 antibody | |
| PGP95 antibody | |
| Protein gene product 9.5 antibody | |
| Ubiquitin C terminal esterase L1 antibody | |
| Ubiquitin C terminal hydrolase antibody | |
| Ubiquitin C terminal hydrolase L1 antibody | |
| Ubiquitin carboxyl terminal esterase L1 antibody | |
| Ubiquitin carboxyl terminal hydrolase isozyme L1 antibody | |
| Ubiquitin carboxyl-terminal hydrolase isozyme L1 antibody | |
| Ubiquitin thioesterase L1 antibody | |
| Ubiquitin thiolesterase antibody | |
| Ubiquitin thiolesterase L1 antibody | |
| UCH-L1 antibody | |
| UCHL1 antibody | |
| UCHL1_HUMAN antibody |
Show More
Target information
Ubiquitin-protein hydrolase involved both in the processing of ubiquitin precursors and of ubiquitinated proteins (Probable). This enzyme is a thiol protease that recognizes and hydrolyzes a peptide bond at the C-terminal glycine of ubiquitin . Also binds to free monoubiquitin and may prevent its degradation in lysosomes (By similarity). The homodimer may have ATP-independent ubiquitin ligase activity.
Miscellaneous
Oxidation of Met-1, Met-6, Met-12, Met-124 and Met-179 to methionine sulfoxide, and oxidation of Cys-220 to cysteine sulfonic acid have been observed in brains from Alzheimer disease (AD) and Parkinson disease (PD) patients. In AD, UCHL1 was found to be associated with neurofibrillary tangles. In contrast to UCHL3, does not hydrolyze a peptide bond at the C-terminal glycine of NEDD8.
Provider
Erpantech Laboratory
